MG
TECH icon

Mather Group’s Bio-Techne TECH Stock Holding History

Mather Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Sell
349
-152
-30% -$8.21K ﹤0.01% 1282
2026
Q1 		$26.2K Buy
+501
New +$30.1K ﹤0.01% 1218
2025
Q4 		– Sell
-217
Closed -$12.1K – 1545
2025
Q3 		$12.1K Buy
+217
New +$11.6K ﹤0.01% 1228
2025
Q2 		– Sell
-1,215
Closed -$71.2K – 1609
2025
Q1 		$71.2K Buy
1,215
+534
+78% +$36.2K ﹤0.01% 835
2024
Q4 		$49.1K Buy
681
+69
+11% +$5.07K ﹤0.01% 879
2024
Q3 		$48.9K Buy
612
+208
+51% +$15.6K ﹤0.01% 883
2024
Q2 		$28.4K Sell
404
-94
-19% -$6.92K ﹤0.01% 1168
2024
Q1 		$38.4K Buy
+498
New +$35.6K ﹤0.01% 927

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mather Group's TECH Position: Q2 2026 in Review

Mather Group reduced its Bio-Techne (TECH) stake by 30% in Q2 2026, selling an estimated $8.21K and leaving 349 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Mather Group first reported a position in TECH in Q1 2024 and has held it in 8 quarters since. The position peaked at $71.2K in Q1 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Mather Group held 349 shares of Bio-Techne worth $24.7K as of Q2 2026.
  • Mather Group sold 152 Bio-Techne shares in Q2 2026, an estimated $8.21K.
  • Bio-Techne made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1282 holding.
  • Mather Group first reported a position in Bio-Techne in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Bio-Techne position peaked at $71.2K in Q1 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.